Lumito AB (publ) (NGM:LUMITO)
2.995
+0.095 (3.28%)
At close: Jul 3, 2026
Lumito AB Company Description
Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden.
The company offers SCIZYS Erbium Kit, an upconverting nanoparticle (UCNP) based IHC kit that enables the identification of biotinylated primary or secondary antibodies in histological samples; SCIZYS S1, a whole slide imaging scanner that images histological samples using brightfield and UCNPs to display both chromogenic counterstaining and UCNP luminescence; and Katana Viewer, the file output format from SCIZYS, OME-TIFF can be used with any software platform.
Its products can be used in drug development, academic research, and clinical diagnostics applications.
Lumito AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden.
Lumito AB (publ)
| Country | Sweden |
| Founded | 2010 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 8 |
| CEO | Sanna Wallenborg |
Contact Details
Address: Scheelevägen 19 Lund, 223 63 Sweden | |
| Phone | 46 1 02 04 00 15 |
| Website | lumito.se |
Stock Details
| Ticker Symbol | LUMITO |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Sanna Wallenborg | Chief Executive Officer |
| Fata Mrsic | Chief Financial Officer |